Click here to get full coverage on New Analyst Forecast: $KROS Given $19 Price Target - Quiver Quantitative

New Analyst Forecast: $KROS Given $19 Price Target  Quiver Quantitative

New Analyst Forecast: $KROS Given $19 Price Target - Quiver Quantitative

Click here to get full coverage on B of A Securities Maintains Keros Therapeutics (KROS) Neutral Recommendation - Nasdaq

B of A Securities Maintains Keros Therapeutics (KROS) Neutral Recommendation  Nasdaq

B of A Securities Maintains Keros Therapeutics (KROS) Neutral Recommendation - Nasdaq

Click here to get full coverage on How Much Upside is Left in Keros Therapeutics (KROS)? Wall Street Analysts Think 34.24% - Yahoo Finance

How Much Upside is Left in Keros Therapeutics (KROS)? Wall Street Analysts Think 34.24%  Yahoo Finance

How Much Upside is Left in Keros Therapeutics (KROS)? Wall Street Analysts Think 34.24% - Yahoo Finance

Click here to get full coverage on Keros Therapeutics (KROS) Gets a Hold from Bank of America Securities - The Globe and Mail

Keros Therapeutics (KROS) Gets a Hold from Bank of America Securities  The Globe and Mail

Keros Therapeutics (KROS) Gets a Hold from Bank of America Securities - The Globe and Mail

Click here to get full coverage on Bank of America Increases Keros Therapeutics (NASDAQ:KROS) Price Target to $19.00 - MarketBeat

Bank of America Increases Keros Therapeutics (NASDAQ:KROS) Price Target to $19.00  MarketBeat

Bank of America Increases Keros Therapeutics (NASDAQ:KROS) Price Target to $19.00 - MarketBeat

Click here to get full coverage on Jason Kros - Men's Tennis Coach - Ole Miss Athletics - Hotty Toddy - Ole Miss Athletics

Jason Kros - Men's Tennis Coach - Ole Miss Athletics - Hotty Toddy  Ole Miss Athletics

Jason Kros - Men's Tennis Coach - Ole Miss Athletics - Hotty Toddy - Ole Miss Athletics

Click here to get full coverage on Keros Therapeutics (Nasdaq: KROS) completes $194M tender offer, buying 35.9% of shares - Stock Titan

Keros Therapeutics (Nasdaq: KROS) completes $194M tender offer, buying 35.9% of shares  Stock Titan

Keros Therapeutics (Nasdaq: KROS) completes $194M tender offer, buying 35.9% of shares - Stock Titan

Click here to get full coverage on Keros Therapeutics, Inc. (NASDAQ:KROS) Held Back By Insufficient Growth Even After Shares Climb 26% - Sahm

Keros Therapeutics, Inc. (NASDAQ:KROS) Held Back By Insufficient Growth Even After Shares Climb 26%  Sahm

Keros Therapeutics, Inc. (NASDAQ:KROS) Held Back By Insufficient Growth Even After Shares Climb 26% - Sahm

Click here to get full coverage on KROS vs. ARGX: Which Stock Is the Better Value Option? - Yahoo Finance

KROS vs. ARGX: Which Stock Is the Better Value Option?  Yahoo Finance

KROS vs. ARGX: Which Stock Is the Better Value Option? - Yahoo Finance

Click here to get full coverage on Men’s Tennis Adds Jason Kros as Assistant Coach - Ole Miss Athletics

Men’s Tennis Adds Jason Kros as Assistant Coach  Ole Miss Athletics

Men’s Tennis Adds Jason Kros as Assistant Coach - Ole Miss Athletics

Click here to get full coverage on Wells Fargo Maintains Keros Therapeutics (KROS) Overweight Recommendation - Nasdaq

Wells Fargo Maintains Keros Therapeutics (KROS) Overweight Recommendation  Nasdaq

Wells Fargo Maintains Keros Therapeutics (KROS) Overweight Recommendation - Nasdaq

Click here to get full coverage on Keros Therapeutics (Nasdaq: KROS) to Repurchase 10.95M Shares for $194.4M in Tender Offer - Stock Titan

Keros Therapeutics (Nasdaq: KROS) to Repurchase 10.95M Shares for $194.4M in Tender Offer  Stock Titan

Keros Therapeutics (Nasdaq: KROS) to Repurchase 10.95M Shares for $194.4M in Tender Offer - Stock Titan

Click here to get full coverage on Keros Therapeutics, Inc. (KROS) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Keros Therapeutics, Inc. (KROS) Reports Q3 Loss, Tops Revenue Estimates  Yahoo Finance

Keros Therapeutics, Inc. (KROS) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Click here to get full coverage on Oppenheimer Reiterates Keros Therapeutics (KROS) Outperform Recommendation - Nasdaq

Oppenheimer Reiterates Keros Therapeutics (KROS) Outperform Recommendation  Nasdaq

Oppenheimer Reiterates Keros Therapeutics (KROS) Outperform Recommendation - Nasdaq

Click here to get full coverage on $194.4M Tender Offer — Keros Therapeutics to Repurchase at $17.75; Part of $375M Program. Expires Nov. 18, 2025 - Stock Titan

$194.4M Tender Offer — Keros Therapeutics to Repurchase at $17.75; Part of $375M Program. Expires Nov. 18, 2025  Stock Titan

$194.4M Tender Offer — Keros Therapeutics to Repurchase at $17.75; Part of $375M Program. Expires Nov. 18, 2025 - Stock Titan

Click here to get full coverage on Wall Street Analysts See a 42.78% Upside in Keros Therapeutics (KROS): Can the Stock Really Move This High? - Yahoo Finance

Wall Street Analysts See a 42.78% Upside in Keros Therapeutics (KROS): Can the Stock Really Move This High?  Yahoo Finance

Wall Street Analysts See a 42.78% Upside in Keros Therapeutics (KROS): Can the Stock Really Move This High? - Yahoo Finance

Click here to get full coverage on Earnings Update: Keros Therapeutics, Inc. (NASDAQ:KROS) Just Reported And Analysts Are Boosting Their Estimates - Yahoo Finance

Earnings Update: Keros Therapeutics, Inc. (NASDAQ:KROS) Just Reported And Analysts Are Boosting Their Estimates  Yahoo Finance

Earnings Update: Keros Therapeutics, Inc. (NASDAQ:KROS) Just Reported And Analysts Are Boosting Their Estimates - Yahoo Finance

Click here to get full coverage on What drives KROS stock price - Straddle and Strangle Trades & Free Dynamic Profit Opportunities - earlytimes.in

What drives KROS stock price - Straddle and Strangle Trades & Free Dynamic Profit Opportunities  earlytimes.in

What drives KROS stock price - Straddle and Strangle Trades & Free Dynamic Profit Opportunities - earlytimes.in

Click here to get full coverage on Keros Therapeutics (NASDAQ:KROS) Shares Gap Down - Here's Why - MarketBeat

Keros Therapeutics (NASDAQ:KROS) Shares Gap Down - Here's Why  MarketBeat

Keros Therapeutics (NASDAQ:KROS) Shares Gap Down - Here's Why - MarketBeat

Click here to get full coverage on Investors in Keros Therapeutics (NASDAQ:KROS) have unfortunately lost 72% over the last year - Yahoo Finance

Investors in Keros Therapeutics (NASDAQ:KROS) have unfortunately lost 72% over the last year  Yahoo Finance

Investors in Keros Therapeutics (NASDAQ:KROS) have unfortunately lost 72% over the last year - Yahoo Finance

Click here to get full coverage on Insider Sale: 10% owner at $KROS Sells 4,391,237 Shares | KROS Stock News - Quiver Quantitative

Insider Sale: 10% owner at $KROS Sells 4,391,237 Shares | KROS Stock News  Quiver Quantitative

Insider Sale: 10% owner at $KROS Sells 4,391,237 Shares | KROS Stock News - Quiver Quantitative

Click here to get full coverage on $375M Capital Return: Keros Therapeutics repurchases $181M, plans $194M tender offer by Oct 2025 - Stock Titan

$375M Capital Return: Keros Therapeutics repurchases $181M, plans $194M tender offer by Oct 2025  Stock Titan

$375M Capital Return: Keros Therapeutics repurchases $181M, plans $194M tender offer by Oct 2025 - Stock Titan

Click here to get full coverage on 'A beer for everybody': Beer brewed in La Vista named official craft beer of the Huskers - KETV

'A beer for everybody': Beer brewed in La Vista named official craft beer of the Huskers  KETV

'A beer for everybody': Beer brewed in La Vista named official craft beer of the Huskers - KETV

Click here to get full coverage on Joseph David Kross - Beaver County Times

Joseph David Kross  Beaver County Times

Joseph David Kross - Beaver County Times

Click here to get full coverage on Killer Kross – Matt Riddle confrontation - mlw.com

Killer Kross – Matt Riddle confrontation  mlw.com

Killer Kross – Matt Riddle confrontation - mlw.com

Click here to get full coverage on Karrion Kross May Get an Oscar After Leaving WWE: All You Need to Know About His Short Film ‘Blue Evening’ - IMDb

Karrion Kross May Get an Oscar After Leaving WWE: All You Need to Know About His Short Film ‘Blue Evening’  IMDb

Karrion Kross May Get an Oscar After Leaving WWE: All You Need to Know About His Short Film ‘Blue Evening’ - IMDb

Click here to get full coverage on Keros Therapeutics (NASDAQ:KROS) Stock Price Expected to Rise, Wedbush Analyst Says - MarketBeat

Keros Therapeutics (NASDAQ:KROS) Stock Price Expected to Rise, Wedbush Analyst Says  MarketBeat

Keros Therapeutics (NASDAQ:KROS) Stock Price Expected to Rise, Wedbush Analyst Says - MarketBeat

Click here to get full coverage on Wells Fargo & Company Lowers Keros Therapeutics (NASDAQ:KROS) Price Target to $23.00 - MarketBeat

Wells Fargo & Company Lowers Keros Therapeutics (NASDAQ:KROS) Price Target to $23.00  MarketBeat

Wells Fargo & Company Lowers Keros Therapeutics (NASDAQ:KROS) Price Target to $23.00 - MarketBeat

Click here to get full coverage on Keros (KROS) launches fixed-price cash tender offer for shares - Stock Titan

Keros (KROS) launches fixed-price cash tender offer for shares  Stock Titan

Keros (KROS) launches fixed-price cash tender offer for shares - Stock Titan

Click here to get full coverage on Can KROS stock beat analyst upgrades - 2025 Sector Review & Fast Exit and Entry Strategy Plans - moha.gov.vn

Can KROS stock beat analyst upgrades - 2025 Sector Review & Fast Exit and Entry Strategy Plans  moha.gov.vn

Can KROS stock beat analyst upgrades - 2025 Sector Review & Fast Exit and Entry Strategy Plans - moha.gov.vn

Click here to get full coverage on KROS vs. EXAS: Which Stock Should Value Investors Buy Now? - Yahoo Finance

KROS vs. EXAS: Which Stock Should Value Investors Buy Now?  Yahoo Finance

KROS vs. EXAS: Which Stock Should Value Investors Buy Now? - Yahoo Finance

Click here to get full coverage on KROS: Wells Fargo Lowers Price Target to $23, Maintains Overweig - GuruFocus

KROS: Wells Fargo Lowers Price Target to $23, Maintains Overweig  GuruFocus

KROS: Wells Fargo Lowers Price Target to $23, Maintains Overweig - GuruFocus

Click here to get full coverage on Killer Kross vs. Matt Riddle Announced for Nov 20 in Charleston - mlw.com

Killer Kross vs. Matt Riddle Announced for Nov 20 in Charleston  mlw.com

Killer Kross vs. Matt Riddle Announced for Nov 20 in Charleston - mlw.com

Click here to get full coverage on KROS: Takeda deal drove $243.7M revenue and $110.5M net income; $375M capital return plan announced - TradingView

KROS: Takeda deal drove $243.7M revenue and $110.5M net income; $375M capital return plan announced  TradingView

KROS: Takeda deal drove $243.7M revenue and $110.5M net income; $375M capital return plan announced - TradingView

Click here to get full coverage on Silliness, suffering and squirrels coming back to Kern Park Kross - OnMilwaukee

Silliness, suffering and squirrels coming back to Kern Park Kross  OnMilwaukee

Silliness, suffering and squirrels coming back to Kern Park Kross - OnMilwaukee

Click here to get full coverage on What is HC Wainwright's Estimate for KROS FY2025 Earnings? - MarketBeat

What is HC Wainwright's Estimate for KROS FY2025 Earnings?  MarketBeat

What is HC Wainwright's Estimate for KROS FY2025 Earnings? - MarketBeat

Click here to get full coverage on KROS Surpasses Revenue Expectations and Advances Clinical Trials - GuruFocus

KROS Surpasses Revenue Expectations and Advances Clinical Trials  GuruFocus

KROS Surpasses Revenue Expectations and Advances Clinical Trials - GuruFocus

Click here to get full coverage on Harry Potter watches are winging their way to Kross Studio - Something About Rocks

Harry Potter watches are winging their way to Kross Studio  Something About Rocks

Harry Potter watches are winging their way to Kross Studio - Something About Rocks

Click here to get full coverage on Released WWE Stars Karrion Kross and Scarlett Share Surprising Career Update - Newsweek

Released WWE Stars Karrion Kross and Scarlett Share Surprising Career Update  Newsweek

Released WWE Stars Karrion Kross and Scarlett Share Surprising Career Update - Newsweek

Click here to get full coverage on Adar1 partners sells Keros Therapeutics (KROS) shares worth $95.6m - Investing.com

Adar1 partners sells Keros Therapeutics (KROS) shares worth $95.6m  Investing.com

Adar1 partners sells Keros Therapeutics (KROS) shares worth $95.6m - Investing.com

Click here to get full coverage on Golden Age Thursday: Redd Kross Turn Pop Excellence Into Raw Punk Energy Live - Glide Magazine

Golden Age Thursday: Redd Kross Turn Pop Excellence Into Raw Punk Energy Live  Glide Magazine

Golden Age Thursday: Redd Kross Turn Pop Excellence Into Raw Punk Energy Live - Glide Magazine

Click here to get full coverage on KROS's Gary Determan still has love for Radio in 50th Season - Clinton Herald

KROS's Gary Determan still has love for Radio in 50th Season  Clinton Herald

KROS's Gary Determan still has love for Radio in 50th Season - Clinton Herald

Click here to get full coverage on Killer Kross & Scarlett Return November 20 LIVE in Charleston, SC - mlw.com

Killer Kross & Scarlett Return November 20 LIVE in Charleston, SC  mlw.com

Killer Kross & Scarlett Return November 20 LIVE in Charleston, SC - mlw.com

Click here to get full coverage on Pontifax funds sell Keros Therapeutics (KROS) shares for $84.97m - Investing.com

Pontifax funds sell Keros Therapeutics (KROS) shares for $84.97m  Investing.com

Pontifax funds sell Keros Therapeutics (KROS) shares for $84.97m - Investing.com

Click here to get full coverage on Karrion Kross comments on WWE’s ‘very gross’ strategy during contract negotiations - Cageside Seats

Karrion Kross comments on WWE’s ‘very gross’ strategy during contract negotiations  Cageside Seats

Karrion Kross comments on WWE’s ‘very gross’ strategy during contract negotiations - Cageside Seats

Click here to get full coverage on Keros Therapeutics (NASDAQ:KROS) Announces Quarterly Earnings Results, Beats Estimates By $0.93 EPS - MarketBeat

Keros Therapeutics (NASDAQ:KROS) Announces Quarterly Earnings Results, Beats Estimates By $0.93 EPS  MarketBeat

Keros Therapeutics (NASDAQ:KROS) Announces Quarterly Earnings Results, Beats Estimates By $0.93 EPS - MarketBeat

Click here to get full coverage on Ex-WWE Power Couple Karrion Kross & Scarlett Drop Jaw-Dropping Pay Bombshell After Shocking Release - ClutchPoints

Ex-WWE Power Couple Karrion Kross & Scarlett Drop Jaw-Dropping Pay Bombshell After Shocking Release  ClutchPoints

Ex-WWE Power Couple Karrion Kross & Scarlett Drop Jaw-Dropping Pay Bombshell After Shocking Release - ClutchPoints

Click here to get full coverage on Build-Outs Of Coffee: Kross Coffee Roasters In Chania, Greece - Sprudge

Build-Outs Of Coffee: Kross Coffee Roasters In Chania, Greece  Sprudge

Build-Outs Of Coffee: Kross Coffee Roasters In Chania, Greece - Sprudge

Click here to get full coverage on Josh Kross - Tablet Magazine

Josh Kross - Tablet Magazine

Click here to get full coverage on Keros Therapeutics: A Potential Dart Throw (NASDAQ:KROS) - Seeking Alpha

Keros Therapeutics: A Potential Dart Throw (NASDAQ:KROS)  Seeking Alpha

Keros Therapeutics: A Potential Dart Throw (NASDAQ:KROS) - Seeking Alpha

Click here to get full coverage on Keros Therapeutics, Inc. (NASDAQ:KROS) Given Average Recommendation of "Hold" by Analysts - MarketBeat

Keros Therapeutics, Inc. (NASDAQ:KROS) Given Average Recommendation of "Hold" by Analysts  MarketBeat

Keros Therapeutics, Inc. (NASDAQ:KROS) Given Average Recommendation of "Hold" by Analysts - MarketBeat

Click here to get full coverage on Keros Therapeutics (KROS) Announces Share Repurchase Agreements - GuruFocus

Keros Therapeutics (KROS) Announces Share Repurchase Agreements  GuruFocus

Keros Therapeutics (KROS) Announces Share Repurchase Agreements - GuruFocus

Click here to get full coverage on Indian Reality TV Gets Korean Makeover as Kross Pictures Unveils Four-Format Slate at Busan Market (EXCLUSIVE) - Variety

Indian Reality TV Gets Korean Makeover as Kross Pictures Unveils Four-Format Slate at Busan Market (EXCLUSIVE)  Variety

Indian Reality TV Gets Korean Makeover as Kross Pictures Unveils Four-Format Slate at Busan Market (EXCLUSIVE) - Variety

Click here to get full coverage on Scarlett, Kross make waves at XICW’s 25th anniversary - Slam Wrestling

Scarlett, Kross make waves at XICW’s 25th anniversary  Slam Wrestling

Scarlett, Kross make waves at XICW’s 25th anniversary - Slam Wrestling

Click here to get full coverage on Karrion Kross Makes Heartbreaking Confession About WWE Departure - Newsweek

Karrion Kross Makes Heartbreaking Confession About WWE Departure  Newsweek

Karrion Kross Makes Heartbreaking Confession About WWE Departure - Newsweek

Click here to get full coverage on Mistico in Opera Cup final, Kross vs. Riddle, title bouts, more on MLW Don Gato special - Cageside Seats

Mistico in Opera Cup final, Kross vs. Riddle, title bouts, more on MLW Don Gato special  Cageside Seats

Mistico in Opera Cup final, Kross vs. Riddle, title bouts, more on MLW Don Gato special - Cageside Seats

Click here to get full coverage on Karrion Kross And Scarlett's First Announced Appearance After WWE Exit Revealed - Sports Illustrated

Karrion Kross And Scarlett's First Announced Appearance After WWE Exit Revealed  Sports Illustrated

Karrion Kross And Scarlett's First Announced Appearance After WWE Exit Revealed - Sports Illustrated

Click here to get full coverage on Pro wrestling stars Killer Kross, Scarlett Bordeaux talk 'very simple decision' to work in MLW again - Fox News

Pro wrestling stars Killer Kross, Scarlett Bordeaux talk 'very simple decision' to work in MLW again  Fox News

Pro wrestling stars Killer Kross, Scarlett Bordeaux talk 'very simple decision' to work in MLW again - Fox News

Click here to get full coverage on Killer Kross And Scarlett Call MLW Return An Easy Choice To Make (Exclusive) - Sports Illustrated

Killer Kross And Scarlett Call MLW Return An Easy Choice To Make (Exclusive)  Sports Illustrated

Killer Kross And Scarlett Call MLW Return An Easy Choice To Make (Exclusive) - Sports Illustrated

Click here to get full coverage on Karrion Kross and Scarlett Moved to WWE Alumni Page, Scarlett Releases Statement - vice.com

Karrion Kross and Scarlett Moved to WWE Alumni Page, Scarlett Releases Statement  vice.com

Karrion Kross and Scarlett Moved to WWE Alumni Page, Scarlett Releases Statement - vice.com

Click here to get full coverage on Karrion Kross Sends Message To Fans Questioning Legitimacy Of WWE Exit - Newsweek

Karrion Kross Sends Message To Fans Questioning Legitimacy Of WWE Exit  Newsweek

Karrion Kross Sends Message To Fans Questioning Legitimacy Of WWE Exit - Newsweek

Click here to get full coverage on Oppenheimer Maintains Keros Therapeutics(KROS.US) With Buy Rating, Maintains Target Price $23 - 富途牛牛

Oppenheimer Maintains Keros Therapeutics(KROS.US) With Buy Rating, Maintains Target Price $23  富途牛牛

Oppenheimer Maintains Keros Therapeutics(KROS.US) With Buy Rating, Maintains Target Price $23 - 富途牛牛

Click here to get full coverage on New Developments Regarding Karrion Kross As WWE Contract Nears Expiration - Sports Illustrated

New Developments Regarding Karrion Kross As WWE Contract Nears Expiration  Sports Illustrated

New Developments Regarding Karrion Kross As WWE Contract Nears Expiration - Sports Illustrated

Click here to get full coverage on Karrion Kross Reveals WWE Gave Him Shocking Contract Ultimatum - Newsweek

Karrion Kross Reveals WWE Gave Him Shocking Contract Ultimatum  Newsweek

Karrion Kross Reveals WWE Gave Him Shocking Contract Ultimatum - Newsweek

Click here to get full coverage on Karrion Kross Breaks Silence On WWE Departure - Newsweek

Karrion Kross Breaks Silence On WWE Departure  Newsweek

Karrion Kross Breaks Silence On WWE Departure - Newsweek

Click here to get full coverage on WWE Fans Claim Debut SmackDown Entrance Copied Karrion Kross - Newsweek

WWE Fans Claim Debut SmackDown Entrance Copied Karrion Kross  Newsweek

WWE Fans Claim Debut SmackDown Entrance Copied Karrion Kross - Newsweek

Click here to get full coverage on Killer Kross And Scarlett Manage Their Business On The Indies With Wrestling Fans In Mind (Exclusive) - Sports Illustrated

Killer Kross And Scarlett Manage Their Business On The Indies With Wrestling Fans In Mind (Exclusive)  Sports Illustrated

Killer Kross And Scarlett Manage Their Business On The Indies With Wrestling Fans In Mind (Exclusive) - Sports Illustrated

Click here to get full coverage on Karrion Kross says WWE pulled contract offer after 24 hours: 'We still want to work it out' - CBS Sports

Karrion Kross says WWE pulled contract offer after 24 hours: 'We still want to work it out'  CBS Sports

KROS

Price Chart

Key Statistics

Technicals

About KROS

Latest News

New Analyst Forecast: $KROS Given $19 Price Target - Quiver Quantitative

B of A Securities Maintains Keros Therapeutics (KROS) Neutral Recommendation - Nasdaq

How Much Upside is Left in Keros Therapeutics (KROS)? Wall Street Analysts Think 34.24% - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers